Term ends no later than Nov 24, 2028 · Medium confidence
20-year base term ends Nov 24, 2028
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Held by Invivo Corporation
Filed Oct 16, 2012 as application 13/653,062 · Granted Jun 3, 2014
Base term, 20 years from filing
Today
2008
2028
Clock starts
Nov 24, 2008
Nov 24, 2008
Ends no later than
Nov 24, 2028
Nov 24, 2028
Granted
Jun 3, 2014
Jun 3, 2014
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 24, 2008, when application 12/277,061, the earliest non-provisional in its chain, was filed (this one was filed Oct 16, 2012) | Nov 24, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Nov 24, 2028 | Medium confidence |
This family
| US 8,290,569 | In force Feb 2031 | Feb 2031 |
| US 8,744,550 | this patent no later than Nov 2028 | no later than Nov 2028 |
| US 9,770,209 | In force Nov 2028 | Nov 2028 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 14, 2012 Reel 29471, frame 910 | Piron, Cameron; Wang, Han; Richmond, Joshua; Jankowski, Jakub; Luginbuhl, Chris | Sentinelle Medical, Inc. | Assignment of Assignor's Interest |
| Dec 14, 2012 Reel 29472, frame 49 | Sentinelle Medical Inc. | Hologic, Inc. | Assignment of Assignor's Interest |
| Jan 11, 2013 Reel 29610, frame 277 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Hologic, Inc.; Goldman Sachs Bank USA | Security Agreement |
| Jan 11, 2013 reel/frame not recorded | Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Hologic, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Hologic, Inc. | Security Agreement |
| Jan 11, 2013 reel/frame not recorded | Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Hologic, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Goldman Sachs Bank USA | Security Agreement |
| Sep 29, 2014 Reel 33845, frame 837 | Goldman Sachs Bank USA | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products , Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Hologic, Inc. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Biolucent, LLC | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Cytyc Corporation | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Cytyc Surgical Products , Limited Partnership | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Direct Radiography Corp. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Suros Surgical Systems, Inc. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Third Wave Technologies, Inc. | Release of Security Interest |
| Sep 29, 2014 reel/frame not recorded | Goldman Sachs Bank USA | Gen-Probe Incorporated | Release of Security Interest |
| Oct 13, 2014 Reel 33973, frame 842 | Sentinelle Medical Inc.; Hologic, Inc. | Invivo Corporation | Assignment of Assignor's Interest |
| Jul 17, 2015 Reel 36126, frame 553 | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Direct Radiography Corp. | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release Reel/Frame 029610 0277 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release Reel/Frame 029610 0277 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2028
Term ends no later than Nov 24, 2028. No further fees fall due before then
Note
A terminal disclaimer is on file and its reference is not resolved. No cap is applied and none is guessed
Open question
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 24, 2028. We will not guess the cap.
Citations
9
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
This computed term ends no later than the date shown; an unresolved terminal disclaimer may end it earlier. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.